AirSeal®Insufflation Trocar/CO2 Absorption Study

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Gynecologic Diseases
Interventions
DEVICE

AirSeal trocar

"The AirSeal® trocar is a valveless trocar that has been designed to replace the trap door and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes."

DEVICE

Standard trocar

"A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a trap door or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas."

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

SurgiQuest, Inc.

INDUSTRY

lead

Columbia University

OTHER

NCT02654808 - AirSeal®Insufflation Trocar/CO2 Absorption Study | Biotech Hunter | Biotech Hunter